Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Nanocluster-antibody-drug conjugates (NADC) as an intravesical precision theranostic agent for interstitial cystitis

PROVIDER: PRJNA1085057 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28288734.fastq.gz	Fastqsanger.gz
	SRR28288735.fastq.gz	Fastqsanger.gz
	SRR28288736.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Urinary extracellular vesicle microRNA profiling for detection in patients with interstitial cystitis

Project description:Urinay miRNAs could be a powerful classifier for the detection of patients with interstitial cystitis

2022-02-05 | GSE196156 | GEO

Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis

Project description:Hunner-type interstitial cystitis (HIC) is a rare, enigmatic inflammatory disease of the urinary bladder with no curative treatments. In this study, we aimed to characterize the unique cellular and immunological factors specifically involved in HIC by comparing with cystitis induced by Mycobacterium bovis bacillus Calmette–Guérin, which presents similar clinicopathological features to HIC. Here, we show that T helper 1/17 polarized immune responses accompanied by prominent overexpression of interferon (IFN)-γ, enhanced cGAS-STING cytosolic DNA sensing pathway, and increased plasma cell infiltration are the characteristic inflammatory features in HIC bladder. Further, we developed a novel mouse anti-IFN-γ DNA aptamer and observed that intravesical instillation of the aptamer significantly ameliorated bladder inflammation, pelvic pain and voiding dysfunction in a recently developed novel murine HIC mouse model with little migration into the blood. Our study provides the plausible basis for clinical translation of the anti-IFN-γ DNA aptamer in the treatment of human HIC.

2023-07-29 | GSE238208 | GEO

Project description:Interstitial Cystitis Longitudinal Urobiome

| PRJNA1141486 | ENA

Project description:Interstitial Cystitis Urinary Metagenomics

| PRJNA679884 | ENA

Advanced dual-payload antibody-drug conjugates (DualADCs) for targeted cancer chemo-immunotherapy

Project description:Antibody–drug conjugates (ADCs) are a powerful class of targeted cancer therapeutics that combine the specificity of monoclonal antibodies with the potency of cytotoxic payloads. In this study, we developed novel dual-payload ADC (DualADC) platforms that enable co-delivery of a chemotherapeutic agent for direct tumor cell killing and a toll-like receptor agonist to stimulate antitumor immunity. Using triple-negative breast cancer (TNBC) as a model, we established advanced cysteine/lysine co-conjugation strategies optimized for antibody–drug ratio (ADR) and drug–drug ratio (DDR). These refinements minimized hydrophobicity-induced precipitation, enhanced conjugation efficiency, and improved formulation stability. In vivo evaluations in two xenograft mouse models demonstrated strong antitumor efficacy, highlighting the therapeutic potential of DualADCs as a next-generation approach for synergistic chemo-immunotherapy.

2026-03-02 | GSE312957 | GEO

Humanized antibody-drug conjugates for SSTR2-positive tumor treatment

Project description:Humanized antibody-drug conjugates for SSTR2-positive tumor treatment

| PRJNA1303643 | ENA

Project description:Assessment of Targets of Antibody Drug Conjugates in SCLC

| PRJNA1180115 | ENA

Development of antibody-drug conjugates targeting L1CAM to treat metastatic cancer

Project description:Development of antibody-drug conjugates targeting L1CAM to treat metastatic cancer

| PRJNA1327350 | ENA

Homo sapiens

Project description:Interstitial cystitis and antiproliferative factor treatment

| PRJNA87523 | ENA

MicroRNAs dysregulation in experimental interstitial cystitis

Project description:MicroRNAs dysregulation in experimental interstitial cystitis

| PRJNA736998 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data